Evidence map›Paper›PMID 22453293›Full record

ArticleEuropean journal of human genetics : EJHG2012

Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users' perspective.

Celine Lewis, Melissa Hill, Heather Skirton, Lyn S Chitty

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Genome-Wide Noninvasive Prenatal Diagnosis of De Novo Mutations.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  8. Article
  9. EMQN best practice guidelines for genetic testing in dystrophinopathies.European journal of human genetics : EJHG · 2020
    Article
  10. Clinical management of woman with bleeding disorders: A survey among European haemophilia treatment centres.Haemophilia : the official journal of the World Federation of Hemophilia · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?Health expectations : an international journal of public participation in health care and health policy · 2015
    Article
  16. Article
  17. Article
  18. Cell-free fetal DNA: the new tool in fetal medicine.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Celine LewisGenetic Alliance UK, London, UK. celine@geneticalliance.org.uk
Melissa Hill
Heather Skirton
Lyn S Chitty
Genetic Alliance UK (United Kingdom) · GBGreat Ormond Street Hospital · GBUniversity College London · GBUniversity of Plymouth · GB

Funding

Department of Health RP-PG-0707-10107
6 · The paper itself

Abstract

Prenatal fetal sex determination is clinically indicated for women who are at risk of having a child with a serious genetic disorder affecting a particular sex. Ultrasound has been the traditional method used, but early fetal sex determination using non-invasive prenatal diagnosis (NIPD) can now be performed using cell-free fetal DNA in maternal plasma. The study aim was to assess the views and experiences of service users who had used NIPD for fetal sex determination. In this paper, we report on the perceived benefits and disadvantages. A qualitative approach using semi-structured interviews was used. A total of 44 participants (38 women and 6 partners of participating women) were recruited. Participants' views and experiences of NIPD were overwhelmingly positive. Concerning benefits over traditional methods, three themes emerged: (1) technical aspects of technology; (2) timing; and (3) enhanced decision-making. Practical advantages of NIPD included avoiding miscarriage, and there were a number of psychological advantages associated with timing such as perceived control, early re-engagement, normalization of pregnancy and peace of mind. Participants also valued NIPD as it enabled a stepwise approach to decision-making. A number of disadvantages were discussed including concerns about social sexing and increased bonding at a time in pregnancy when miscarriage risk is high. However, participants felt these were fairly minor in comparison with the advantages of NIPD. Until definitive genetic diagnosis using NIPD is available, NIPD for fetal sex determination is perceived as a good interim measure with a number of notable advantages over traditional methods.

Indexed as

AdultAttitudeFemaleGenetic TestingHumansMalePatientsPregnancyPrenatal DiagnosisQuality ControlSex Determination AnalysisSurveys and Questionnaires

Identifiers

PMID22453293
PMCPMC3476712
OpenAlexW2012462356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.